OR WAIT null SECS
June 24, 2025
Podcast
Explore the urgent need for diabetes specialists and the American College of Diabetology's efforts to enhance care through education and certification.
June 23, 2025
Discover how the CATALYST trial reveals mifepristone's potential to enhance glycemic control and weight loss in challenging type 2 diabetes cases.
Explore groundbreaking findings from the REDEFINE trials on CagriSema's impact on weight loss and diabetes management at ADA 2025.
June 22, 2025
Kevin Sayer joins the program to discuss the latest from Dexcom and preview where the business is headed in an evolving diabetes landscape.